ACTIVE

PHARMACIE SMITS ZONING NORD

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result-32,9 k €-138,0 %over 1 year
Gross margin267 k €-26,1 %over 1 year
Equity-729,1 k €-4,7 %over 1 year
Workforce3,0 ETP+30,4 %over 1 year

Identity

Source · BCE/KBO

PHARMACIE SMITS ZONING NORD is a Private limited company incorporated in 2010. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Wavre. It employs on average 3,0 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0824.354.302
Incorporation
26/03/2010
Legal form
Private limited company
Registered office
Place Cardinal Mercier 6
1300 Wavre · WallonieSee on map
Contributed capital
160 000,00 €
Latest accounts
31/12/2025
Average workforce
3,0 ETP
Joint committees (1)
  • 313
Signals
Positive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 16 filings

Trend over 16 financial years

20252024202320222021
Income statement
Gross margin267 k €361,3 k €256,3 k €271,7 k €383,5 k €
EBITDA79,1 k €187 k €84,9 k €155,2 k €183,9 k €
Operating result24,3 k €152,9 k €2 k €60,3 k €97,6 k €
Net result-32,9 k €86,7 k €-76,9 k €13,4 k €50,6 k €
Balance sheet
Equity-729,1 k €-696,1 k €-782,8 k €-705,9 k €-719,2 k €
Total assets816,7 k €871,3 k €872,5 k €964,8 k €1 M €
Cash34,7 k €81,6 k €61,2 k €80,7 k €131,5 k €
Debts1,5 M €1,6 M €1,7 M €1,7 M €1,7 M €
Other
Workforce3,0 ETP2,3 ETP2,6 ETP1,9 ETP3,7 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 0 € and 100 k€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

1 active

Active mandates

JEAN-JACQUES SMITS

Manager · since 26 mars 2010

Active

Other companies at this address

Place Cardinal Mercier 6 1300 Wavre
CompanyCBE no.
GS Motorsport Management● Active
0744.877.450
PHARMACIE SMITS ECHT● Active
0644.564.109
PHARMA PROJECT● Active
0458.257.001
Pharma Project II● Active
0823.439.235

Full financial information

Source · NBB
202520242023202220212020
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date22/07/202601/07/202504/07/202429/06/202315/07/202230/06/2021
General meeting08/06/202610/06/202510/06/202412/06/202313/06/202214/06/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 16 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202508/06/202622/07/2026FrenchPDF
Abridged model31/12/202410/06/202501/07/2025FrenchPDF
Abridged model31/12/202310/06/202404/07/2024FrenchPDF
Abridged model31/12/202212/06/202329/06/2023FrenchPDF
Abridged model31/12/202113/06/202215/07/2022FrenchPDF
Abridged model31/12/202014/06/202130/06/2021FrenchPDF
Abridged model31/12/201908/06/202013/07/2020FrenchPDF
Abridged model31/12/201811/06/201917/06/2019FrenchPDF
Abridged model31/12/201711/06/201816/07/2018FrenchPDF
Abridged model31/12/201612/06/201719/07/2017FrenchPDF
Abridged model31/12/201513/06/201601/08/2016FrenchPDF
Abridged model31/12/201408/06/201530/07/2015FrenchPDF
Abridged model31/12/201310/06/201417/07/2014FrenchPDF
Abridged model31/12/201210/06/201324/06/2013FrenchPDF
Abridged model31/12/201111/06/201205/07/2012FrenchPDF
Abridged model31/12/201014/06/201116/08/2011FrenchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 0 € and 100 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

1 active

Active mandates

JEAN-JACQUES SMITS

Manager · since 26 mars 2010

Active

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Other01/02/2024
    MODIFICATION FORME JURIDIQUE
    PDF
  • Mandates09/10/2023
    DEMISSIONS, NOMINATIONS
    PDF
  • Capital / shares25/01/2018
    OBJET - CAPITAL, ACTIONS
    PDF
  • Mandates13/09/2013
    DENOMINATION
    PDF
  • Other30/03/2010
    RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025-32,9 k €↓
  2. 2024
    Annual accounts 202486,7 k €↑
  3. 2023
    Annual accounts 2023-76,9 k €↓
  4. 2022
    Annual accounts 202213,4 k €↓
  5. 2021
    Annual accounts 202150,6 k €↑
  6. 2021
    Name changeSMITS ZONING NORD
  7. 2020
    Annual accounts 2020-10,9 k €↑
  8. 2019
    Annual accounts 2019-12,9 k €↑
  9. 2018
    Annual accounts 2018-48,2 k €↑
  10. 2017
    Annual accounts 2017-87,3 k €↑
  11. 2016
    Annual accounts 2016-112,1 k €↑
  12. 2015
    Annual accounts 2015-184,5 k €↑
  13. 2014
    Annual accounts 2014-187,6 k €↑
  14. 2013
    Annual accounts 2013-204 k €↓
  15. 2013
    Name changePHARMACIE SMITS ZONING NORD
  16. 2012
    Annual accounts 2012-49,3 k €↓
  17. 2011
    Annual accounts 2011-16,5 k €↓
  18. 2010
    Annual accounts 2010-16,5 k €
  19. 26/03/2010
    IncorporationPrivate limited company
  20. 2010
    Name changePharma Project III